Does childhood vaccination and exposure to infection improve long-term survival in patients with malignant melanoma?
Tarhini
Ahmad A
AA
University of Pittsburgh Cancer Institute, PA 15213, USA.
Land
Stephanie
S
Gupta
Akshay
A
Kirkwood
John M
JM
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000008:administration & dosage / Q000276:immunology*; D016022:Case-Control Studies; D002648:Child; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008017:Life Expectancy; D008297:Male; D008545:Melanoma / Q000276:immunology* / Q000401:mortality* / Q000601:surgery; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000276:immunology* / Q000401:mortality* / Q000601:surgery; D012900:Smallpox Vaccine / Q000008:administration & dosage / Q000276:immunology*; D016019:Survival Analysis; D014376:Tuberculosis / Q000517:prevention & control; D014611:Vaccination
D001500:BCG Vaccine; D012900:Smallpox Vaccine